Young Alethia — SEC insider filings

SEC reporting owner CIK 1918147. 19 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2022-04-05 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PTC THERAPEUTICS, INC. (PTCT)Director6—2 legs · 11,666 sh · $464,97216
BICYCLE THERAPEUTICS PLC (BCYC)Chief Financial Officer6—7 legs · 8,524 sh · $57,7625
Pacira BioSciences, Inc. (PCRX)Director5——12
Graphite Bio, Inc. (GRPH)Chief Financial Officer2——2

Insider filings — Young Alethia

FiledFormIssuerReported transactionsSource
2026-11-174Pacira BioSciences, Inc. (PCRX)Disposition to issuer (D): 17,798 @ $36.50 · Disposition to issuer (D): 12,179 (derivative) · Disposition to issuer (D): 11,279 (derivative) · Disposition to issuer (D): 10,891 (derivative) · Disposition to issuer (D): 30,967 (derivative)EDGAR
2026-06-124Pacira BioSciences, Inc. (PCRX)Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0EDGAR
2026-01-064PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 4,000 @ $0 · Grant/award (A): 3,475 (derivative) @ $0EDGAR
2026-01-064BICYCLE THERAPEUTICS PLC (BCYC)Grant/award (A): 50,000 @ $0 · Sale (S): 3,289 @ $6.80 · Sale (S): 2,456 @ $6.45 · Sale (S): 1,878 @ $6.54 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-10-064BICYCLE THERAPEUTICS PLC (BCYC)Sale (S): 217 @ $8.40 · Sale (S): 265 @ $8.61EDGAR
2025-07-074BICYCLE THERAPEUTICS PLC (BCYC)Sale (S): 204 @ $7.09EDGAR
2025-06-134Pacira BioSciences, Inc. (PCRX)Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0EDGAR
2025-04-044BICYCLE THERAPEUTICS PLC (BCYC)Sale (S): 215 @ $8.02EDGAR
2025-01-074PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 4,000 @ $0 · Grant/award (A): 8,800 (derivative) @ $0EDGAR
2024-06-134Pacira BioSciences, Inc. (PCRX)Grant/award (A): 5,230 @ $0 · Grant/award (A): 12,179 (derivative) @ $0EDGAR
2024-02-164PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 4,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2024-01-044BICYCLE THERAPEUTICS plc (BCYC)Grant/award (A): 12,000 @ $0 · Grant/award (A): 24,000 (derivative) @ $0EDGAR
2023-10-114Pacira BioSciences, Inc. (PCRX)Grant/award (A): 30,967 (derivative) @ $0EDGAR
2023-09-084PTC THERAPEUTICS, INC. (PTCT)Option exercise (M): 7,000 @ $27.85 · Sale (S): 7,000 @ $39.90 · Option exercise (M): 4,666 @ $27.85 · Sale (S): 4,666 @ $39.79 · Option exercise (M): 7,000 (derivative) @ $27.85 · Option exercise (M): 4,666 (derivative) @ $27.85EDGAR
2023-07-194BICYCLE THERAPEUTICS plc (BCYC)Grant/award (A): 120,000 (derivative) @ $0EDGAR
2023-02-234Graphite Bio, Inc. (GRPH)Grant/award (A): 220,000 (derivative) @ $0EDGAR
2023-01-094PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 4,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-06-104PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 3,200 @ $0 · Grant/award (A): 1,867 @ $0 · Grant/award (A): 12,000 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0EDGAR
2022-04-054Graphite Bio, Inc. (GRPH)Grant/award (A): 350,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1918147 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs